MRTFA and osteosarcoma: Fasudil exerts its effects by inhibiting megakaryoblastic leukemia 1 (MKL1), thereby preventing MKL1-mediated suppression of PPARγ, which leads to enhanced adipogenesis in osteosarcoma cells (Tabe et al., 2017; Rosenwald et al., 2017).